Development and Implementation of Papillomavirus Prophylactic Vaccines

@article{Frazer2014DevelopmentAI,
  title={Development and Implementation of Papillomavirus Prophylactic Vaccines},
  author={I. Frazer},
  journal={The Journal of Immunology},
  year={2014},
  volume={192},
  pages={4007 - 4011}
}
  • I. Frazer
  • Published 2014
  • Medicine
  • The Journal of Immunology
    • Translation of basic scientific findings into practical patient outcomes is a significant exercise even when the goal is conceptually straightforward, as in the development of a vaccine for an infectious disease. Recognition of the association of cervical cancer with papillomavirus infection encouraged development of a vaccine to help with prevention of this very common cancer, causing over 250,000 deaths each year worldwide. To introduce a vaccine program, it was however necessary to develop a… CONTINUE READING
    View on AAI
    jimmunol.org
    30 Citations
    Background Citations
    11
    30 Citations
    Citation Type

    Citation Type

    A novel "priming-boosting" strategy for immune interventions in cervical cancer.
    • 9
    Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development
    • 1
    Construction and evaluation of human papillomavirus genotype 18 pseudovirions
    • 1
    • PDF
    Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology
    • 16
    • PDF
    The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
    • 59
    HPV Vaccine: Updates and Highlights
    • 10
    Rodent Papillomaviruses
    • 7
    • PDF
    Impact of HPV vaccination on anogenital warts and respiratory papillomatosis
    • 19
    Therapeutic DNA Vaccine Against HPV16-Associated Cancer.
    • 1
    Fifty years of immunisation in Australia (1964–2014): The increasing opportunity to prevent diseases
    • 6

    References

    SHOWING 1-10 OF 60 REFERENCES
    Prophylactic human papillomavirus vaccines.
    • 415
    • PDF
    Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
    • 61
    Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
    • 43
    Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
    • J. Suzich, S. Ghim, +6 authors R. Schlegel
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1995
    • 663
    • Highly Influential
    • PDF
    Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
    • 591
    • PDF
    Comprehensive control of human papillomavirus infections and related diseases.
    • 123
    New Approaches to Immunotherapy for HPV Associated Cancers
    • 33
    • PDF
    Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes.
    • 109
    • PDF
    Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses
    • 68
    Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
    • 81